CIPLA LTD vs SUVEN LIFE SCIENCES LTD
A side-by-side comparison of CIPLA LTD (CIPLA) and SUVEN LIFE SCIENCES LTD (SUVEN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, CIPLA LTD leads CIPLA vs SUVEN on 12 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability40
- Growth10
- Size & financial health40
Valuation
CIPLA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
CIPLA takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
CIPLA takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
CIPLA takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
- − ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
- + ["Company is almost debt free."]
- − ["Stock is trading at 16.3 times its book value", "Company has low interest coverage ratio.", "Promoter holding has decreased over last quarter: -4.68%", "The company has delivered a poor sales growth of -12.0% over past five years.", "Company has a low return on equity of -65.9% over last 3 years.", "Debtor days have increased from 63.7 to 77.5 days.", "Working capital days have increased from 55.6 days to 506 days"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.